Azora Therapeutics (AZR) vs Citius Oncology (CTOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Azora Therapeutics is the larger company by market cap ($55.0 million vs $53.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZR | CTOR |
|---|---|---|
| Share price | $3.85 | $0.5035 |
| Market cap | $55.00M | $53.25M |
| 1-day change | -0.52% | -10.95% |
| YTD return | — | -49.65% |
| 1-year return | — | -55.44% |
| EPS (TTM) | $-18.09 | $-0.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-7.98M | $-24.76M |
| 52-week high | $8.25 | $1.83 |
| 52-week low | $1.31 | $0.491 |
| Distance from 52-week high | -53.33% | -72.49% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +694.44% |
| Average volume | 50.12K | 114.02K |
| Shares outstanding | 14.29M | 105.76M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations
AZR vs CTOR FAQ
Which is bigger, Azora Therapeutics or Citius Oncology?
Azora Therapeutics (AZR) is larger, with a market capitalization of $55.00M compared with $53.25M for Citius Oncology (CTOR).
Are Azora Therapeutics and Citius Oncology in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.